PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
187 hedge funds and large institutions have $387M invested in PDL BioPharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 60 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
52% less call options, than puts
Call options by funds: $186K | Put options by funds: $388K
Holders
187
Holding in Top 10
–
Calls
$186K
Puts
$388K
Top Buyers
| 1 | +$4.61M | |
| 2 | +$3.93M | |
| 3 | +$2.84M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.83M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$2.73M |
Top Sellers
| 1 | -$5.32M | |
| 2 | -$3.49M | |
| 3 | -$2.32M | |
| 4 |
Bank of New York Mellon
New York
|
-$2.21M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.7M |